Revolution Medicines, Inc.
DE ˙ DB ˙ US76155X1000
135,15 € ↑1,10 (0,82%)
2026-06-03
AKTIENPREIS
SecurityDE:42Z / Revolution Medicines, Inc.
InstitutionInvesco Ltd.
Latest Disclosed Ownership392,844 shares
Latest Disclosed Value $ 38,204,080
Invesco Ltd. reports 6.79% increase in ownership of 42Z / Revolution Medicines, Inc.

On May 12, 2026 - Invesco Ltd. filed a 13F-HR form disclosing ownership of 392,844 shares of Revolution Medicines, Inc. (DE:42Z) valued at $32,213,208 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 19, 2026 disclosing 367,851 shares of Revolution Medicines, Inc.. This represents a change in shares of 6.79% during the quarter. The current value of the position is $53,092,867 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F REVOLUTION MEDICINES COM 76155X100 392,844 24,993 6.79 38,204 30.39 0.0007
2026-02-19 2025-12-31 13F REVOLUTION MEDICINES COM 76155X100 367,851 166,909 83.06 29,299 212.26 0.0045
2025-11-13 2025-09-30 13F REVOLUTION MEDICINES COM 76155X100 200,942 -26,077 -11.49 9,384 12.34 0.0015
2025-08-13 2025-06-30 13F REVOLUTION MEDICINES COM 76155X100 227,019 36,760 19.32 8,352 24.16 0.0014
2025-05-12 2025-03-31 13F REVOLUTION MEDICINES COM 76155X100 190,259 72,607 61.71 6,728 30.72 0.0013
2025-02-13 2024-12-31 13F REVOLUTION MEDICINES COM 76155X100 117,652 -29,594 -20.10 5,146 -22.93 0.0010
2024-11-12 2024-09-30 13F REVOLUTION MEDICINES COM 76155X100 147,246 48,695 49.41 6,678 74.61 0.0013
2024-08-13 2024-06-30 13F REVOLUTION MEDICINES COM 76155X100 98,551 4,120 4.36 3,825 25.67 0.0008
2024-05-14 2024-03-31 13F REVOLUTION MEDICINES COM 76155X100 94,431 -34,387 -26.69 3,044 -17.62 0.0007
2024-02-13 2023-12-31 13F REVOLUTION MEDICINES COM 76155X100 128,818 -76,584 -37.28 3,694 -35.02 0.0009
2023-11-13 2023-09-30 13F REVOLUTION MEDICINES COM 76155X100 205,402 134,536 189.85 5,686 200.00 0.0015
2023-08-11 2023-06-30 13F REVOLUTION MEDICINES COM 76155X100 70,866 10,348 17.10 1,896 44.66 0.0005
2023-05-12 2023-03-31 13F REVOLUTION MEDICINES COM 76155X100 60,518 33,925 127.57 1,311 106.95 0.0004
2023-02-13 2022-12-31 13F REVOLUTION MEDICINES COM 76155X100 26,593 -329 -1.22 633 19.43 0.0002
2022-11-14 2022-09-30 13F REVOLUTION MEDICINES COM 76155X100 26,922 3,837 16.62 530 17.78 0.0002
2022-08-15 2022-06-30 13F REVOLUTION MEDICINES COM 76155X100 23,085 146 0.64 450 -23.21 0.0001
2022-05-16 2022-03-31 13F REVOLUTION MEDICINES COM 76155X100 22,939 206 0.91 586 2.27 0.0001
2022-02-14 2021-12-31 13F REVOLUTION MEDICINES COM 76155X100 22,733 2,984 15.11 573 5.52 0.0001
2021-11-15 2021-09-30 13F REVOLUTION MEDICINES COM 76155X100 19,749 -3,873 -16.40 543 -27.60 0.0001
2021-08-17 2021-06-30 13F REVOLUTION MEDICINES COM 76155X100 23,622 14,568 160.90 750 80.72 0.0002
2021-05-17 2021-03-31 13F REVOLUTION MEDICINES COM 76155X100 9,054 -8,099 -47.22 415 -38.88 0.0001
2021-02-16 2020-12-31 13F REVOLUTION MEDICINES COM 76155X100 17,153 17,153 679 0.0002
2020-11-16 2020-09-30 13F REVOLUTION MEDICINES COM 76155X100 0 -16,485 -100.00 0 -100.00
2020-08-14 2020-06-30 13F REVOLUTION MEDICINES COM 76155X100 16,485 16,485 521 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.